RadioMedix, Inc. is a clinical-stage biotechnology company, based in Texas, focused on innovative targeted radiopharmaceuticals for diagnosis, monitoring, and therapy of cancer. We commercialize radiopharmaceuticals for PET imaging and targeted alpha and beta-emitter therapy.
Our operations cover the entire value chain from drug discovery to sponsoring and conducting clinical trials to scale up manufacturing. RadioMedix is c...
RadioMedix, Inc. is a clinical-stage biotechnology company, based in Texas, focused on innovative targeted radiopharmaceuticals for diagnosis, monitoring, and therapy of cancer. We commercialize radiopharmaceuticals for PET imaging and targeted alpha and beta-emitter therapy.
Our operations cover the entire value chain from drug discovery to sponsoring and conducting clinical trials to scale up manufacturing. RadioMedix is compliant with 21 CFR Parts 210,211,212. Our Molecular Core Facility supports the synthesis, and the pre-clinical evaluation of our drugs and contract projects.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.